Adaptive Biotechnologies Corp (ADPT) — Cash Flow Reinvestment Rate

Latest as of March 2019: 0.81x

Adaptive Biotechnologies Corp (ADPT) has a Cash Flow Reinvestment Rate of 0.81x as of March 2019, reinvesting $226.01 Million (capex $3.83 Million plus investments $-222.18 Million) from operating cash flow of $278.30 Million. Explore how much does Adaptive Biotechnologies Corp reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.81x
(Capex + Investments) / Operating CF

Total Reinvested

$226.01 Million
Capex + Investments

Operating Cash Flow

$278.30 Million
USD

Capital Expenditures

$3.83 Million
USD

Adaptive Biotechnologies Corp Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Adaptive Biotechnologies Corp across 1 annual periods. Also explore Adaptive Biotechnologies Corp (ADPT) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Adaptive Biotechnologies Corp (2019–2019)

Year-by-year capital reinvestment analysis for Adaptive Biotechnologies Corp. For live market cap and broader valuation context, see Adaptive Biotechnologies Corp (ADPT) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2019 2.35x $481.70 Million $205.40 Million $11.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow